Characterization of the rearranged tpr-met oncogene breakpoint
about
Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptorsEvolutionary conservation and expression of human RNA-binding proteins and their role in human genetic diseaseBiology of MET: a double life between normal tissue repair and tumor progressionMet receptor tyrosine kinase: enhanced signaling through adapter proteinsTwo rearranged MET alleles in MNNG-HOS cells reveal the orientation of MET on chromosome 7 to other markers tightly linked to the cystic fibrosis locusDisassociation of met-mediated biological responses in vivo: the natural hepatocyte growth factor/scatter factor splice variant NK2 antagonizes growth but facilitates metastasis.Localization of preferential sites of rearrangement within the BCR gene in Philadelphia chromosome-positive acute lymphoblastic leukemiaDiverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factorCompilation of DNA strand exchange sites for non-homologous recombination in somatic cells.Illegitimate recombination in an Escherichia coli plasmid: modulation by DNA damage and a new bacterial geneMET meet adaptors: functional and structural implications in downstream signalling mediated by the Met receptor.From Tpr-Met to Met, tumorigenesis and tubes.Characterization of the TPR-MET oncogene p65 and the MET protooncogene p140 protein-tyrosine kinases.Epigenetic activation of AP1 promotes squamous cell carcinoma metastasis.TPR-MET oncogenic rearrangement: detection by polymerase chain reaction amplification of the transcript and expression in human tumor cell lines.New targeted therapies for gastric cancer.Specific Grb2-mediated interactions regulate clathrin-dependent endocytosis of the cMet-tyrosine kinase.Structural Basis of TPR-Mediated Oligomerization and Activation of Oncogenic Fusion Kinases.C-Met/miR-130b axis as novel mechanism and biomarker for castration resistance state acquisition.Increased engraftment of hepatic progenitors after activation of the hepatocyte growth factor signaling pathway by protein transduction.Immunogold labeling of oncogenic and tumor related proteins.Nucleotide sequence of both reciprocal translocation junction regions in a patient with Ph positive acute lymphoblastic leukaemia, with a breakpoint within the first intron of the BCR gene.Tyrosine kinase receptors in the control of epithelial growth and morphogenesis during development.Met-induced JNK activation is mediated by the adapter protein Crk and correlates with the Gab1 - Crk signaling complex formation.Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development.Activated HGF-c-Met Axis in Head and Neck Cancer.Anti-Differentiation Effect of Oncogenic Met Receptor in Terminally-Differentiated Myotubes.
P2860
Q24339620-B33067E3-241E-4560-894D-33B664AF3625Q26991754-DD32E788-9656-4278-B03F-D08716941993Q28085247-175E3CF6-72B3-4AF8-9240-815ECA359A29Q28140219-CD9587D2-59CD-4489-B7A7-54193F28B39DQ33567327-8D8B1B36-8EC3-41D2-B312-D8F34B07513DQ33786959-46B22C41-905D-4A23-9162-ACD2629B1DAFQ33867942-BFA5FE87-482B-41D0-BD5F-BFFAE68FEE6EQ35961109-806244C2-49CC-458A-9125-2D95961784CBQ36054067-3CC77F86-2081-45A4-958E-38BD27A81329Q36206645-5CEDC523-4671-4DB8-804A-957174B31B62Q36245150-9C659252-B83B-4059-8ED6-890EB1CA6CC3Q36745364-BA53F14F-6841-4B08-AC92-864DDB265204Q37479257-2592546B-01E3-4C93-8821-D08F956D22BEQ37632913-AE8AC5BE-8FF2-424B-9B9B-1B6087176C0AQ37677630-C6F48ADA-FF6E-4AAF-849B-65BC4FD327E6Q37853198-462EC029-210C-46A1-89E7-F86847CC1ACAQ38302515-64C927A0-447F-45EC-90B5-C1B45A047843Q38431115-3248392C-3E43-49F8-81EA-720CD2860259Q38964120-327E2866-92D7-4197-A8CE-F986569E7BA4Q39834676-F083AEC3-0CF7-40E9-8CF1-DED9E23B3B58Q40471164-3A3F4D77-F412-43EE-A8C8-E8122761437AQ40520345-6F43285F-F28E-4147-843C-A4D4258482B9Q40853801-98D84050-79E5-423A-BF43-CDE3056FBDE1Q41711750-A728A078-CFA6-4F22-8D85-9C99B3E6E7F2Q42770153-66491035-5E26-4DB4-8B3E-51FFFD615F26Q47303095-B8C7EFD3-9CE1-46EF-866B-9C1BA80CF23EQ50985099-E0ED72FA-6272-4F9B-9108-8850132BE6AF
P2860
Characterization of the rearranged tpr-met oncogene breakpoint
description
1987 nî lūn-bûn
@nan
1987 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
name
Characterization of the rearranged tpr-met oncogene breakpoint
@ast
Characterization of the rearranged tpr-met oncogene breakpoint
@en
Characterization of the rearranged tpr-met oncogene breakpoint
@nl
type
label
Characterization of the rearranged tpr-met oncogene breakpoint
@ast
Characterization of the rearranged tpr-met oncogene breakpoint
@en
Characterization of the rearranged tpr-met oncogene breakpoint
@nl
prefLabel
Characterization of the rearranged tpr-met oncogene breakpoint
@ast
Characterization of the rearranged tpr-met oncogene breakpoint
@en
Characterization of the rearranged tpr-met oncogene breakpoint
@nl
P2093
P2860
P356
P1476
Characterization of the rearranged tpr-met oncogene breakpoint
@en
P2093
P2860
P304
P356
10.1128/MCB.7.2.921
P407
P577
1987-02-01T00:00:00Z